Application of integrated psychosomatic assessment and intervention in the prevention and treatment of pre-diabetes

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300079245

Enrollment

Unknown

Registered

2023-12-28

Start date

2024-04-01

Completion date

Unknown

Last updated

2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

(Part 2) Mind-Body Stance Group:1.Having diabetes health education, including guidance on dieat, daily routine, excercise ,etc. 2.Mantain 12 weeks of exercise on the Mind-Body Stance

(Part 2) Control Group:Will have diabetes health education, including guidance on dieat, daily routine, excercise ,etc. and totally mantain 12 weeks.

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (Part 1): This study aims to include currently employed individules between the ages of 20-77 at a certain university as research participants,and who are willing to complete a questionaire survey and provide medical examination data from 2021 to 2023. (Part 2): (1)Those who can meet the above diagnostic criteria of pre-diabetes . (2)Age from 18-69 years old, male and females(non pregnancy and non lactation). (3)No important organ disease such as lung,liver,kidney,etc. ,and no mental consciousness disorders. (4)Urinary, liver function,blood, and renal funtion without abnor malities. (5)Those who have not applied medication to control blood glucose . (6) Voluntarily and signed (7)Can operating cell phone.

Exclusion criteria

Exclusion criteria: (Part 1): Those who cannot complete the questionaire survey and cannot provide medical examination data from 2021-2023. (Part 2): (1)Used drugs affect blood glucuse level with in two weeks. (2)Have other endocrine diseases. (3)WIth combined liver,kidney,hematological disorders,and psychiatric disorders. (4)Pregnant and lactating individuals. (5)Current participants in other clinical studies and treatment. (6)Poor compliance,unable to complete the guidance plan and treatment.

Design outcomes

Secondary

Measure	Time frame
TC (Part 2);TG (Part 2);LDL-C (Part 2);HDL-C (Part 2);BMI (Part 2);Leptin (Part 2);Blood pressure (Part 2);Weight (Part 2);Waist circumference (Part 2);Hip circumference (Part 2);	—

Primary

Measure	Time frame
FBG (Part 2);2hPG (Part 2);HbA1c (Part 2);Psychosomatic questionnaire (Part 1);Annual physical examination data (Part 1);SF-36 scale (Part 2);TCM Syndrome Score Scale (Part 2);	—

Countries

China

Contacts

Public ContactYang Shuyu

Department of The First Hospital of Xiamen University, China

xmyangshuyu@xmu.edu.com+86 139 5006 2003

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026